News

Fixed Phage invests in continued improvement to Glasgow facilities

DATE: 16th December 2022

Following an extensive laboratory and office improvement project in 2021, the company has further invested in facilities in Q4 2022.

The programme has involved undertaking extensive improvements of additional laboratories ensuring safety and quality compliance, with maximal productivity.  The completion of this work provides a facility that will be able to support increased capacity and capability in current development projects as well as future project needs.

 

Chris Bindon, Operations Director for Fixed Phage said: 

Fixed Phage is committed to continuous improvement in our skills and training, facilities and capabilities through our core technology programme, professional development, and capital investment. These are key to scaling the company’s activities and continued success in the development and commercialisation of phage solutions and are fundamental to supporting our current and future programmes.   

Related Articles

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or...
DATE: 29th May 2023

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or ineffective at killing bacteria and treating infections. We urgently need new therapeutic strategies to combat...

  Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its...
DATE: 26th May 2023

  Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its new Chief Executive Officer (CEO). The company has also announced its new Chief Operations Officer...

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research...
DATE: 17th May 2023

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research topic with significant implications for human health and the environment. Bacteriophage-based solutions can be applied...